SOURCE: TomoTherapy


February 05, 2010 09:05 ET

TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 17, 2010

MADISON, WI--(Marketwire - February 5, 2010) - TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it will release its 2009 fourth-quarter results on Wednesday, February 17, 2010 at 3:00 p.m. CT.

TomoTherapy will hold an investment community conference call on Wednesday, February 17, 2010 beginning at 4:00 p.m. CT. Fred Robertson, M.D., CEO, and Thomas Powell, CFO, will review fourth-quarter performance and discuss the company's strategies. To join the conference call, dial 1-866-804-6922 (international 1-857-350-1668) and enter passcode 19106554. A replay of the conference call will be available at 7:00 p.m. CT on February 17, 2010, through 11:59 p.m. CT on February 24, 2010. To access the replay, dial 1-888-286-8010 (international 1-617-801-6888) and enter passcode 75521447.

For individual investors, a live Webcast of the conference call will be available on the Investor Relations page of Institutional investors can access the Webcast through a password-protected site An archived Webcast of TomoTherapy's conference call will be available for two weeks.

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi-Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi-Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Contact Information

  • Investor Contact:
    Thomas E. Powell
    Chief Financial Officer
    Email Contact

    Media Contacts:
    Kevin O'Malley
    Manager, Corporate Communications
    Email Contact